502 related articles for article (PubMed ID: 19335727)
1. HIV vaccines under study.
Ravanfar P; Mendoza N; Satyaprakash A; Jordan BI
Dermatol Ther; 2009; 22(2):158-67. PubMed ID: 19335727
[TBL] [Abstract][Full Text] [Related]
2. AIDS vaccine: efficacy, safety and ethics.
Veljkovic V; Veljkovic N; Glisic S; Ho MW
Vaccine; 2008 Jun; 26(24):3072-7. PubMed ID: 18164521
[TBL] [Abstract][Full Text] [Related]
3. Challenges in the development of an effective HIV vaccine: current approaches and future directions.
Klein E; Ho RJ
Clin Ther; 2000 Mar; 22(3):295-314; discussion 265. PubMed ID: 10963285
[TBL] [Abstract][Full Text] [Related]
4. The prospects for vaccines against HIV-1: more than a field of long-term nonprogression?
Sheppard N; Sattentau Q
Expert Rev Mol Med; 2005 Feb; 7(2):1-21. PubMed ID: 15710051
[TBL] [Abstract][Full Text] [Related]
5. Progress towards an HIV-1 subtype C vaccine.
Nkolola JP; Essex M
Vaccine; 2006 Jan; 24(4):391-401. PubMed ID: 16139396
[TBL] [Abstract][Full Text] [Related]
6. Current strategies and limitations of HIV vaccines.
Kawalekar OU; Shedlock DJ; Weiner DB
Curr Opin Investig Drugs; 2010 Feb; 11(2):192-202. PubMed ID: 20112169
[TBL] [Abstract][Full Text] [Related]
7. A safe, effective and affordable HIV vaccine--an urgent global need.
Joseph J; Etcheverry F; Alcami J; María GJ
AIDS Rev; 2005; 7(3):131-8. PubMed ID: 16302460
[TBL] [Abstract][Full Text] [Related]
8. Novel strategies toward the development of an effective vaccine to prevent human immunodeficiency virus infection or acquired immunodeficiency virus.
Ensoli B; Cafaro A
AIDS Clin Rev; 2000-2001; ():23-61. PubMed ID: 10999215
[No Abstract] [Full Text] [Related]
9. Therapeutic vaccine trails in Thailand.
Churdboonchart V
J HIV Ther; 2004 Sep; 9(3):57-9. PubMed ID: 15534562
[TBL] [Abstract][Full Text] [Related]
10. The potential role of the HIV-1 immunogen (Remune) as a therapeutic vaccine in the treatment of HIV infection.
Fernández-Cruz E; Navarro J; Rodríguez-Sainz C; Gil J; Moreno S; González-Lahoz J; Carbone J
Expert Rev Vaccines; 2003 Dec; 2(6):739-52. PubMed ID: 14711358
[TBL] [Abstract][Full Text] [Related]
11. A review of vaccine research and development: the human immunodeficiency virus (HIV).
Girard MP; Osmanov SK; Kieny MP
Vaccine; 2006 May; 24(19):4062-81. PubMed ID: 16530298
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and the emergence of human immunodeficiency virus and acquired immune deficiency syndrome.
De Cock KM
Philos Trans R Soc Lond B Biol Sci; 2001 Jun; 356(1410):795-8. PubMed ID: 11405922
[TBL] [Abstract][Full Text] [Related]
13. The development of HIV-1 subtype C vaccines for Southern Africa.
Williamson AL
IUBMB Life; 2002; 53(4-5):207-8. PubMed ID: 12120996
[TBL] [Abstract][Full Text] [Related]
14. Fifty volunteer for live-vaccine trial.
James JS
AIDS Treat News; 1997 Oct; (No 280):1-2. PubMed ID: 11364735
[TBL] [Abstract][Full Text] [Related]
15. First phase I clinical trial of an HIV-1 subtype D gp140 envelope protein vaccine: immune activity induced in all study participants.
Hurwitz JL; Lockey TD; Jones B; Freiden P; Sealy R; Coleman J; Howlett N; Branum K; Slobod KS
AIDS; 2008 Jan; 22(1):149-51. PubMed ID: 18090404
[TBL] [Abstract][Full Text] [Related]
16. Outstanding questions on HIV vaccine trial.
Jefferys R; Harrington M
Science; 2004 Jul; 305(5681):180; author reply 180. PubMed ID: 15247456
[No Abstract] [Full Text] [Related]
17. [The HIV vaccine].
Smith KA
Zhonghua Nan Ke Xue; 2004 Oct; 10(10):723-8. PubMed ID: 15562781
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 vaccine clinical trials: the Brazilian experience.
Ersching J; Pinto AR
Rev Med Virol; 2009 Sep; 19(5):301-11. PubMed ID: 19650156
[TBL] [Abstract][Full Text] [Related]
19. Mapping the future of HIV vaccines.
Nabel GJ
Nat Rev Microbiol; 2007 Jul; 5(7):482-4. PubMed ID: 17571457
[No Abstract] [Full Text] [Related]
20. [HIV/AIDS vaccines: heading for new vaccine approaches?].
Girard MP
Bull Soc Pathol Exot; 2008 Jun; 101(3):220-6. PubMed ID: 18681215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
